Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-04-13

Clinical Trial Update: Esomeprazole and Radiation Induced Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether esomeprazole can prevent or reduce radiation-induced esophagitis in locally advanced non-small cell lung cancer is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole (Esomeprazole)

Snippet

Sponsor: Rush University Medical Center | Conditions: Radiation Esophagitis, Locally Advanced Lung Carcinoma | Phase 2 | Status: RECRUITING